首页 工具
登录
购物车

搜索结果

Search Results for " castration "

38

抑制剂 & 化合物

5

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T8217 Enzalutamide carboxylic acid

Androgen Receptor; Drug Metabolite Endocrinology/Hormones; Metabolism
Enzalutamide carboxylic acid 是 Enzalutamide 非活性代谢物。Enzalutamide 是雄激素受体 (AR) 拮抗剂。
T21740 RD162

Androgen Receptor Endocrinology/Hormones
RD162 是一种与雄激素受体 (AR) 特异性结合的非甾体抗雄激素 (NSAA)。
T6889 MI-136

Apoptosis; Epigenetic Reader Domain; Androgen Receptor Apoptosis; Chromatin/Epigenetic; Endocrinology/Hormones
MI136 是 menin-MLL(PPI) 蛋白互作的抑制剂,其 IC50值为31 nM,Kd 值为23.6 nM。它可抑制 DHT 诱导的雄激素受体 (AR) 靶基因的表达,有用于去势抵抗性肿瘤的潜能。
T9246 JNJ-63576253

Androgen Receptor Endocrinology/Hormones
JNJ63576253 是具有口服活性的、有效的雄激素受体的完全拮抗剂,在 LNCaP 细胞中对 F877L 突变型 AR 和野生型 AR 的IC50值分别为 37 和 54 nM。它可用于研究去势抵抗性前列腺癌。
T22263 Bavdegalutamide

ARV-110

Androgen Receptor Endocrinology/Hormones
Bavdegalutamide (ARV-110) 是一种雄激素受体 (AR) 的 PROTAC 降解剂。 Bavdegalutamide 可用于前列腺癌的研究。 Bavdegalutamide 具有口服活性和选择性,并促进 AR 的泛素化和降解。
T36841 IPI-9119

Fatty Acid Synthase Metabolism
IPI-9119 是一种具有口服活性、选择性和不可逆的 FASN 抑制剂 (IC50 = 0.3 nM)。
T0380 Bicalutamide

比卡鲁胺,ICI-176334

Androgen Receptor; Autophagy Autophagy; Endocrinology/Hormones
Bicalutamide (ICI-176334) 是一种具有口服活性的非甾体雄激素受体拮抗剂,可研究前列腺癌。
T8933 JNJ-63576253 free base

TRC253,JNJ-63576253

Androgen Receptor Endocrinology/Hormones
JNJ-63576253 free base (TRC253) 是具有口服活性的、有效的雄激素受体的完全拮抗剂,在 LNCaP 细胞中对 F877L 突变型 AR 和野生型 AR 的 IC50值分别为 37 和 54 nM。它可用于研究去势抵抗性前列腺癌 (CRPC) 。
T0272 Nilutamide

尼鲁米特,RU23908

Androgen Receptor Endocrinology/Hormones
Nilutamide (RU23908) 是一种非甾体抗雄激素药物,有用于转移性前列腺癌的潜力。
T8497 SX-682

CXCR Autophagy; GPCR/G Protein; Immunology/Inflammation
SX-682 是口服有效的 CXCR1和 CXCR2变构抑制剂,可以阻断肿瘤髓系抑制细胞募集并增强 T 细胞活化和抗肿瘤免疫,具有治疗去势抵抗性前列腺癌的潜力。
T13363 Y06137

Epigenetic Reader Domain; PKC Chromatin/Epigenetic; Cytoskeletal Signaling
Y06137 是一种有效的特异性 BET 抑制剂,对 BRD4(1) 溴结构域的 Kd 为 81 nM。 Y06137可用于去势抵抗性前列腺癌治疗的研究。
T6215 Abiraterone Acetate

Zytiga,乙酸阿比特龙酯,CB7630

P450 Metabolism
Abiraterone Acetate (CB7630) 是一种具有口服活性的、不可逆的 CYP17A1选择性抑制剂,具有抗雄激素作用。它是 Abiraterone 的前药。
T7752 (S,R,S)-AHPC-Me

VHL ligand 2,E3 ligase Ligand 1A

Ligand for E3 Ligase PROTAC
(S,R,S)-AHPC-Me (E3 ligase Ligand 1A) 是基于 (S,R,S)-AHPC 的的 VHL 配体,可用于募集 von Hippel-Lindau (VHL) 蛋白。它可有效降解去势抵抗性前列腺癌细胞中的 BET 蛋白,DC50<1 nM。它可用于合成 ARV-771。
T76758 Rilotumumab

AMG 102

c-Met/HGFR Tyrosine Kinase/Adaptors
Rilotumumab (AMG 102) 是一种针对肝细胞生长因子的单克隆抗体,对 HGF/MET 驱动的信号传导有抑制作用。Rilotumumab 具有抗肿瘤作用,可用于研究去势抵抗性前列腺癌 (CRPC) 和胃癌。
T13671 (S,R,S)-AHPC-Me hydrochloride

VHL ligand 2 hydrochloride,E3 ligase Ligand 1

Others; Ligand for E3 Ligase Others; PROTAC
(S,R,S)-AHPC-Me hydrochloride (VHL ligand 2 hydrochloride) is a chemical compound utilized in the synthesis of ARV-771, an exceptionally potent BET protein degrader. This compound selectively degrades BET protein in cells resistant to castration, exhibiting a remarkable DC50 <1 nM. Recognized as VHL ligand 2 hydrochloride, (S,R,S)-AHPC-Me hydrochloride serves as the VHL ligand derived from (S,R,S)-AHPC for the recruitment of von Hippel-Lindau (VHL) protein.
T76743 Emibetuzumab

LY2875358

c-Met/HGFR Tyrosine Kinase/Adaptors
Emibetuzumab 是一种有效的人源化二价 MET 抗体 (IgG4 型)。Emibetuzumab 具有抗肿瘤活性,对 HGF 依赖性和非依赖性 MET 通路的激活和肿瘤生长有抑制作用可用于研究晚期去势抵抗性前列腺癌。
T30876 CHF 2819

Ganstigmine HCl,CHF-2819,Ganstigmine hydrochloride,CHF2819

CH-5137291 is a pure AR antagonist with AR nuclear translocation inhibition activity. It suppresses castration and prevents the growth of prostate cancer cells.
T26831 BKM1644

BKM 1644,BKM-1644

BKM1644 is an effective inhibition of the proliferation of metastatic, castration-resistant PCa (mCRPC) cells.
T69874 LLS30

LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 decreases Gal-1 binding affinity to its binding partners, and potentially overcomes metastatic castration-resistant prostate cancer (mCRPC).
T30877 CHF-1024

UNII-HPH2L3QA2F

CH-5137291 is a pure AR antagonist with AR nuclear translocation inhibition activity. It inhibits castration and prevents the growth of prostate cancer cells.
T17930 EC1167

Others Others
EC1169 is a targeted tubulysin conjugate that utilizes EC1167 as its linker. This compound shows promise in the treatment of recurrent metastatic, castration-resistant prostate cancer (MCRPC)[1].
T30868 CH-5137291

CH 5137291,CH5137291

CH-5137291 is a pure AR antagonist with AR nuclear translocation inhibition activity. It suppresses castration and prevents the growth of prostate cancer cells.
T61109 HG122

HG122 is a chemical compound that effectively facilitates the degradation of androgen receptor (AR) via the proteasome pathway, leading to the inhibition of castration-resistant prostate cancer.
T75058 RLA-5331

RLA-5331,一种含有抗雄激素的铁活化剂,针对(mCRPC)细胞系显示出抗增殖活性。
T6051 Orteronel

TAK-700,(S)-Orteronel

P450 Metabolism
(S)-Orteronel ((S)-Orteronel) 是人17,20-裂解酶 (17,20-lyase, CYP17) 选择性抑制剂(IC50:38 nM),CYP17对(S)-Orteronel 选择性比对 11-hydroxylase 及 CYP3A4 高 1000 多倍。
T61335 Rucaparib hydrochloride

Rucaparib hydrochloride, also known as AG014699, is a powerful and orally active compound that inhibits PARP proteins including PARP-1, PARP-2, and PARP-3 with a Ki value of 1.4 nM for PARP1. Additionally, Rucaparib hydrochloride acts as a modest inhibitor of hexose-6-phosphate dehydrogenase (H6PD). This compound shows potential in research for castration-resistant prostate cancer (CRPC) [1] [2] [3] [4].
T74094 5,6-Dihydroabiraterone

5,6-Dihydroabiraterone 是 Abiraterone 的代谢物。Abiraterone 是一种强效且不可逆的 CYP17A1抑制剂,具有抗雄激素活性,并在 CRPC (去势抵抗性前列腺癌) 中显示出抗肿瘤活性。
T61653 VPC-13789

VPC-13789 is a highly potent, selective, and orally bioavailable antiandrogen compound that shows promise for studying and developing therapeutics for castration-resistant prostate cancer (CRPC). In LNCaP cells, VPC-13789 effectively inhibits the transcriptional activity of the androgen receptor (AR) with an IC50 value of 0.19 μM [1].
T75057 RLA-4842

RLA-4842,含有抗雄激素性质的铁活化剂,表现出对于转移性去势抵抗性前列腺癌(mCRPC)细胞系的抗增殖活性。
T74520 TD-802

TD-802 (Compound 33c) 是一种雄激素受体 (androgen receptor)PROTAC 降解剂。TD-802 具有良好的体内抗肿瘤效果,能被用于转移性去势抵抗性前列腺癌的研究。
T77815 EC1167 hydrochloride

EC1167 hydrochloride为EC1169的linker,后者是针对前列腺特异性膜抗原的小管溶解蛋白偶联物。EC1169 hydrochloride展现了对治疗复发性转移性去势性前列腺癌(MCRPC)的研究潜力。
T77130 Pasotuxizumab

Pasotuxizumab (BAY 2010112) 是一种 PSMA 和 CD3双特异性的 T 细胞接合剂 (BiTE)。Pasotuxizumab 可结合CD3和 PSMA,对人CD3和 PSMA 的KD 分别为 9.4 nM 和 47.0 nM。Pasotuxizumab 可用于转移性去势抵抗性前列腺癌 (mCRPC) 的研究。
T61657 Rucaparib acetate

Rucaparib (AG014699) acetate is a highly effective oral inhibitor of PARP proteins, specifically targeting PARP-1, PARP-2, and PARP-3, with a Ki value of 1.4 nM for PARP1. Additionally, it exhibits inhibitory action on hexose-6-phosphate dehydrogenase (H6PD) to a moderate extent. Rucaparib acetate shows promise in the field of research for castration-resistant prostate cancer (CRPC). [1] [2] [3] [4]
T13671L (S,R,S)-AHPC-Me dihydrochloride

VHL ligand 2 dihydrochloride,E3 ligase Ligand 1 dihydrochloride,(S,R,S)-AHPC-Me dihydrochloride (1948273-02-6 free base)

Others Others
(S,R,S)-AHPC-Me dihydrochloride, also known as VHL ligand 2 dihydrochloride, is a chemical compound utilized in the synthesis of ARV-771. ARV-771, a BET PROTAC degrader relying on von Hippel-Landau (VHL) E3 ligase, demonstrates potent degradation of BET protein in castration-resistant prostate cancer (CRPC) cells, with a DC50 of less than 1 nM. This compound serves as the VHL ligand, specifically the (S,R,S)-AHPC-based VHL ligand, that facilitates the recruitment of von Hippel-Lindau (VHL) prote...
T71113 Minnelide free acid

Minnelide is an effective therapy against pancreatic cancer. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants. Minnelide reduced tumor volume in multiple models of pancreatic cancer. Minnelide was a more effective drug against pancreatic cancer models. It effectively reduced tumor burden and tumor related morbidity in different unique but complementary mouse models. It reduced metastat...
T36980 Histone H3K27Me1 (23-34) (trifluoroacetate salt)

Histone H3K27Me1 (23-34) (trifluoroacetate salt)

Histone H3K27Me1 (23-34) is a peptide fragment of histone H3 that corresponds to amino acid residues 24-35 of the human histone H3.1 and H3.2 sequences. Monomethylation of histone H3 at lysine 27 is associated with actively transcribed genes and positively correlates with H3K36 trimethylation. Levels of H3K27Me1 are increased in tumor tissue isolated from patients with metastatic hormone-na ve and castration-resistant prostate cancer. Histone H3K27Me1 (23-34) has been used in epitope mapping of ...
T77072 Lorigerlimab

Lorigerlimab (MGD019) 为一种IgG4双特异性双亲和力再靶向抗体 (DART)。该化合物通过阻断PD-1与CTLA-4来提升T细胞反应效率,目前正被应用于转移性去势抵抗性前列腺癌 (mCRPC) 研究中。
T68292 GTX-758

GTX-758, also known as Capesaris, is a n orally available, nonsteroidal selective estrogen receptor (ER) alpha agonist with potential antineoplastic activity. Upon administration of GTx-758, this agent suppresses the secretion of the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH) by the pituitary gland through feedback inhibition. In males, the inhibition of LH secretion prevents the synthesis of androgens, including testosterone, by the testes. This may result in ...

化合物

Enzalutamide carboxylic acid
Cat.No: T8217
Synonym:
Target: Androgen Receptor, Drug Metabolite
RD162
Cat.No: T21740
Synonym:
Target: Androgen Receptor
MI-136
Cat.No: T6889
Synonym:
Target: Apoptosis, Epigenetic Reader Domain, Androgen Receptor
JNJ-63576253
Cat.No: T9246
Synonym:
Target: Androgen Receptor
Bavdegalutamide
Cat.No: T22263
Synonym: ARV-110
Target: Androgen Receptor
IPI-9119
Cat.No: T36841
Synonym:
Target: Fatty Acid Synthase
Bicalutamide
Cat.No: T0380
Synonym: 比卡鲁胺,ICI-176334
Target: Androgen Receptor, Autophagy
JNJ-63576253 free base
Cat.No: T8933
Synonym: TRC253,JNJ-63576253
Target: Androgen Receptor
Nilutamide
Cat.No: T0272
Synonym: 尼鲁米特,RU23908
Target: Androgen Receptor
SX-682
Cat.No: T8497
Synonym:
Target: CXCR
Y06137
Cat.No: T13363
Synonym:
Target: Epigenetic Reader Domain, PKC
Abiraterone Acetate
Cat.No: T6215
Synonym: Zytiga,乙酸阿比特龙酯,CB7630
Target: P450
(S,R,S)-AHPC-Me
Cat.No: T7752
Synonym: VHL ligand 2,E3 ligase Ligand 1A
Target: Ligand for E3 Ligase
Rilotumumab
Cat.No: T76758
Synonym: AMG 102
Target: c-Met/HGFR
(S,R,S)-AHPC-Me hydrochloride
Cat.No: T13671
Synonym: VHL ligand 2 hydrochloride,E3 ligase Ligand 1
Target: Others, Ligand for E3 Ligase
Emibetuzumab
Cat.No: T76743
Synonym: LY2875358
Target: c-Met/HGFR
CHF 2819
Cat.No: T30876
Synonym: Ganstigmine HCl,CHF-2819,Ganstigmine hydrochloride,CHF2819
Target:
BKM1644
Cat.No: T26831
Synonym: BKM 1644,BKM-1644
Target:
LLS30
Cat.No: T69874
Synonym:
Target:
CHF-1024
Cat.No: T30877
Synonym: UNII-HPH2L3QA2F
Target:
EC1167
Cat.No: T17930
Synonym:
Target: Others
CH-5137291
Cat.No: T30868
Synonym: CH 5137291,CH5137291
Target:
HG122
Cat.No: T61109
Synonym:
Target:
RLA-5331
Cat.No: T75058
Synonym:
Target:
Orteronel
Cat.No: T6051
Synonym: TAK-700,(S)-Orteronel
Target: P450
Rucaparib hydrochloride
Cat.No: T61335
Synonym:
Target:
5,6-Dihydroabiraterone
Cat.No: T74094
Synonym:
Target:
VPC-13789
Cat.No: T61653
Synonym:
Target:
RLA-4842
Cat.No: T75057
Synonym:
Target:
TD-802
Cat.No: T74520
Synonym:
Target:
EC1167 hydrochloride
Cat.No: T77815
Synonym:
Target:
Pasotuxizumab
Cat.No: T77130
Synonym:
Target:
Rucaparib acetate
Cat.No: T61657
Synonym:
Target:
(S,R,S)-AHPC-Me dihydrochloride
Cat.No: T13671L
Synonym: VHL ligand 2 dihydrochloride,E3 ligase Ligand 1 dihydrochloride,(S,R,S)-AHPC-Me dihydrochloride (1948273-02-6 free base)
Target: Others
Minnelide free acid
Cat.No: T71113
Synonym:
Target:
Histone H3K27Me1 (23-34) (trifluoroacetate salt)
Cat.No: T36980
Synonym: Histone H3K27Me1 (23-34) (trifluoroacetate salt)
Target:
Lorigerlimab
Cat.No: T77072
Synonym:
Target:
GTX-758
Cat.No: T68292
Synonym:
Target:
Cat. No. Product Name Target Signaling Pathways
T2895 Lupeol

Fagarasterol,羽扇豆醇,Monogynol B,Clerodol,(3β,13ξ)-Lup-20(29)-en-3-ol,Farganasterol

Apoptosis; Androgen Receptor; Akt Apoptosis; Cytoskeletal Signaling; Endocrinology/Hormones; PI3K/Akt/mTOR signaling
Lupeol (Monogynol B) 是一个活跃的五环三萜,具有抗氧化剂、抗肿瘤和抗炎活性。它是一种雄激素受体抑制剂,可研究癌症,特别是雄激素依赖表型和去势抵抗表型的前列腺癌。
TQ0214 Dimethylcurcumin

ASC-J9,二甲基姜黄素,GO-Y025

Androgen Receptor Endocrinology/Hormones
Dimethylcurcumin (ASC-J9) 是雄激素受体降解增强剂,能够有效抑制耐药性前列腺癌细胞增殖和侵袭。
T2543 Cabazitaxel

XRP6258,卡巴他塞,RPR-116258A,TXD 258,taxoid XRP6258

Microtubule Associated; Autophagy Autophagy; Cytoskeletal Signaling
Cabazitaxel (taxoid XRP6258) 是一种紫杉烷类的抗肿瘤剂,可用于治疗多西他赛失败后的去势抵抗性转移性前列腺癌。
T39071 Thailanstatin D

Thailanstatin D, an analogue of Thailanstatin A, inhibits AR-V7 gene splicing by disrupting the interaction between U2AF65 and SAP155, hindering their binding to the polypyrimidine tract situated between the branch point and the 3' splice site. This compound displays potent tumor inhibitory properties in human castration-resistant prostate cancer (CRPC) xenografts, resulting in cellular apoptosis.
T82326 Genkwadaphnin

Genkwadaphnin是一种瑞香烷二萜,能够靶向内输蛋白importin-β1,减少CRPC核心驱动因子在细胞核内的积累,并关闭其下游致癌信号通路。此外,Genkwadaphnin在小鼠体内显现出能显著抑制去势抵抗性前列腺癌(CRPC)发展的抗癌活性。

天然产物

Lupeol
Cat.No: T2895
Synonym: Fagarasterol,羽扇豆醇,Monogynol B,Clerodol,(3β,13ξ)-Lup-20(29)-en-3-ol,Farganasterol
Target: Apoptosis, Androgen Receptor, Akt
Dimethylcurcumin
Cat.No: TQ0214
Synonym: ASC-J9,二甲基姜黄素,GO-Y025
Target: Androgen Receptor
Cabazitaxel
Cat.No: T2543
Synonym: XRP6258,卡巴他塞,RPR-116258A,TXD 258,taxoid XRP6258
Target: Microtubule Associated, Autophagy
Thailanstatin D
Cat.No: T39071
Synonym:
Target:
Genkwadaphnin
Cat.No: T82326
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼